ArticleJAMA network open2019

Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies.

Kiu Tay-Teo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.